religionconservative

Harmless Collagen Choices for Muslim Patients

MalaysiaFriday, June 26, 2026

The review examines how various collagen sources align with Islamic regulations and the implications for medicines used by Muslim patients.

Key Points

  • Global Production
  • Pig collagen constitutes ~41% of worldwide collagen production.
  • Many Muslims consider pork forbidden, raising concerns about adherence to halal principles in pharmaceuticals.

  • Research Scope
  • 56 papers from five databases were analyzed, categorized into four focus areas:
    1. Islamic legal perspectives on each collagen source.
    2. Scientific methods for identifying collagen types in products.
    3. Available halal alternatives.
    4. Governmental approval frameworks for drugs.

Islamic Law Perspectives

  • Pig Collagen
  • Universally deemed haram (forbidden) by Sunni scholars, regardless of processing method.
  • Supported by classical texts and contemporary fatwas.

  • Cow Collagen
  • Permissible if the animal was slaughtered according to Islamic rites and its source is traceable.

  • Fish Collagen
  • Widely accepted and already integrated into many products.

Detection Techniques

Collagen State Preferred Method Rationale
Intact proteins Sensitive DNA assay Detects minute amounts with high specificity
Fragmented collagen Protein‑analysis (multi‑site) Captures partial molecular signatures
Highest certainty Dual‑test approach Combines DNA and protein analyses for confirmation

Emerging Alternatives

  • Lab‑grown Collagen
  • Produced from engineered cells, eliminating animal origins.
  • Currently expensive and lacks widespread regulatory approval.

Regulatory Landscape

  • Country Variations
  • Halal medicine regulations differ globally.
  • A unified standard could streamline compliance and improve patient trust.

Practical Implications

  • Stakeholders
  • Pharmacists, regulators, and clinicians serving Muslim communities will benefit from these insights.
  • Research Gap
  • Limited studies focus specifically on joint diseases; further investigation is warranted.

Actions